What's in a Name? For a Drug Maker, It Could Mean Big Profits
Wall Street Journal-5 hours agoFor their part, generic drug makers believe that different names for biosimilars may confuse prescribers and pharmacists as they sort out whether the medicines ...
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Friday, June 12, 2015
What's in a Name? For a Drug Maker, It Could Mean Big Profits
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment